Chinese firm Sinovac 99% sure COVID-19 vaccine will work - To be Ready by Year End

[Kool_SRG]

The company published results of the vaccine named CoronaVac in the academic journal Science last month that protected monkeys from infection by the coronavirus.

 

Chinese biopharmaceutical company Sinovac Biotech has said that it is 99% sure that their COVID-19 vaccine will work.

The company reached stage 2 of the coronavirus vaccine trial with more than 1000 volunteers participating. The company is in preliminary talks to hold stage 3 trials - the final part of the process in the UK.

As per a Sky News report, Luo Baishan, a researcher at Sinovac, when asked whether he thought the vaccine would be successful.

 

"Yes, yes. It must be successful… 99% [sure]," he replied.

 

The company published results of the vaccine named CoronaVac in the academic journal Science last month that protected monkeys from infection by the coronavirus.

Due to low number of cases in China, the company is now looking for a different place for stage 3 trials.

The report quoted Helen Yang, senior director of investor relations, as saying: "We are speaking to several European countries and I think did discuss with the UK as well. Currently it's a very preliminary stage for the discussion."

The company confirmed that construction of a production plant near Beijing was concurrently under way with an aim of being able to produce 100 million doses.

"It is our recommendation that it is not the whole population that gets the vaccine," Ms Yang said as per the report .

"We are firstly targeting high-risk groups, for example, health workers or senior citizens, who may have a higher level of fatality rate. I think that will be the starting point. To be frank, the vaccine needs to be produced lot by lot," she further said.

The stage 2 trials have months to run before Stage 3 can begin, Ms Yang pointed out that the vaccine won't be here soon.

"It's very hard to say, very difficult to say at the moment. There are uncertainties, but the data: so far, so good," she added.

"We are already considering not only China but also the whole world, not only for conducting a trial but also how to supply a solution for countries including China and outside China," she said.

 

 

[Kool_SRG]

Chinese Covid-19 vaccine expected to begin mass output this year

The production line for the vaccine will be fully disinfected and closed in preparation for output to start Saturday, and will have a full manufacturing capacity of 100 million-120 million vaccines each year.

 

A front-running Covid-19 vaccine candidate being developed in China is expected to be available as soon as the end of this year, according to a report published in the official Wechat account of the State-owned Assets Supervision and Administration Commission.

The vaccine, jointly developed by the Beijing Institute of Biological Products and China National Biotec Group Co., has completed phase II testing and may be ready for the market at the end of this year or early next year, said the report.

The production line for the vaccine will be fully disinfected and closed in preparation for output to start Saturday, and will have a full manufacturing capacity of 100 million-120 million vaccines each year.

Drugmakers are racing to develop a cure for the contagion that has so far killed at least 365,000 people. More than 100 vaccines for the virus are being developed globally, but only a handful have made it to the crucial and final human clinical trial stage, with Chinese scientists leading the way.

 

In total, five vaccines developed by Chinese companies are being tested on humans, the most in any country. Beijing has mobilized its health authorities, drug regulators and research institutes to work around the clock with local companies to come up with the world’s first successful one for Covid-19.

President Xi Jinping has promised to share any successful vaccine globally, but Chinese companies still face challenges. Phase III testing needs to be done in a place where the coronavirus is still spreading rapidly, and China’s cases have dwindled to a handful each day. Also, an effective vaccine needs massive production capabilities in order to meet global distribution demands.

The vaccine candidate from Beijing Institute of Biological Products and China National Biotec Group employs a killed version of the novel coronavirus that can still trigger an immune response. Such inactivated vaccines have been developed for many years to protect populations from diseases including polio and hepatitis.

 

While inactivated vaccines may be slower to develop initially, their familiar path to mass production might allow them to overtake shots made by newer, cutting-edge approaches.

[Kool_SRG]

China-made Covid-19 vaccine could be out by year-end

More than 100 vaccines for the virus are being developed globally, and in China, a total of five vaccines are being developed and tested on humans.

A Covid-19 vaccine under development in China could be in the market by the end of the year, a government body affiliated to the country’s cabinet, the State Council, has announced.

The vaccine is being jointly developed by the Wuhan Biological Products Research Institute and Beijing Biological Products Research Institute and have completed two phases of clinical or human trials, the State-owned Assets Supervision and Administration Commission (SASAC) announced in a social media post on its WeChat account.

Both entities are affiliated with government-owned pharmaceutical group Sinopharm.

More than 2000 people have received the vaccine in the first two phases of the trial.

 

“It is reported that the clinical trial is divided into three phases, the completion of phase I-III clinical till come into the market, it is expected to be the end of this year or early next year at the earliest,” the announcement said.

The announcement added that data from the two first two phases of clinical trials show that the candidate vaccine’s safety and efficacy were better than other vaccines under development.

More than 100 vaccines for the virus are being developed globally, and in China, a total of five vaccines are being developed and tested on humans.

 

Meanwhile, Wuhan is set to complete the ambitious task of conducting nucleic acid tests (NAT) on all its residents to check for asymptomatic patients.

Between May 15 and 25, Wuhan medics tested more than 6.5 million residents, a state media report said, adding at least 218 among them were found to be asymptomatic.

The mass testing is part of China’s efforts to fortify against a potential “second wave” after a cluster of cases emerged in a residential community earlier this month.

 

To carry out the tests in time, health workers collected and mixed 10 to 20 samples and carried out a single test on them; If the collected sample was positive, each individual was tested again to identify which person was positive.

[xano917]

china ni nammina vaadu yevada

[JaiTDP]

Li8

[pahelwan]

Ee lambidikodkula deggara eppudo vaccine undi but don’t want to bring it out. Trying to get the world countries under their control with this news. 

[LadiesTailor]

Amma puttinillu menamama ki eruka ani old samethe vundi.... virus puttinchina vaadiki vaccine telvada 😜😜